Tranexamic Acid During Upper GI Endoscopic Resection Procedures
Status:
Not yet recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
Endoscopic resection of gastrointestinal lesions may prevent cancer. However, resection is
associated with adverse events such as bleeding. Tranexamic acid (TXA) is a synthetic
derivative of lysine that exerts antifibrinolytic effects and may prevent bleeding. The
investigators aim to evaluate the effect of local TXA on preventing intraprocedural and
postprocedural bleeding in patients undergoing endoscopic mucosal resection (EMR) of upper
gastrointestinal lesions.